About 20% of former Ozempic and Wegovy users regain weight: new study

health

by alex mitchell

Is Ozempic over?

New research shows that in certain cases, about one in five patients are unable to maintain the weight they lost with the help of drugs.

report Published in Epic Research Users of diabetes drugs such as Ozempic and Wegovy (which exploded in popularity for their role as weight loss aids) were 17.7% more likely, if not more likely, to stop taking them after they stopped taking them. I discovered that I had regained all of my weight.

The 20,274 patients in the study, who were observed one year after discontinuing use, each lost at least 5 pounds while taking drugs such as the semaglutide family Ozempic.

Similarly, 18.7% experienced similar symptoms with liraglutide injections like Saxenda.

“I started gaining weight like never before,” said Artemis Bayandor, 41, a former Wegovy user. told the messenger.

Since she first lost 15 pounds before quitting, she had weighed 246 pounds and had a very strong appetite, which the medication suppressed.

“I felt insatiable. And I've never been like that. I was so hungry. The feeling was crazy,” she added.

“It was terrible, and it's still terrible.”

However, studies have shown that the majority of two-thirds of users who stopped taking either semaglutide or liraglutide for a year were able to continue the weight loss they started while on the shot.

Additionally, 56.2% of patients were able to maintain the same weight or continued to lose weight when they quit smoking.

Of the 17,733 study participants who lost at least 5 pounds on liraglutide before discontinuing use, 55.7% stayed the same weight or continued to lose weight.

An unrelated study also recently revealed that Ozempic may also act as a liver cancer prevention drug in certain diabetics.